Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt by Dahal, A, Shakya, M, Pant, D, Adhikari, A, Colin-Jones, R, Theiss-Nyland, K, Pollard, AJ, Basnyat, B, Shrestha, S

“…To generate evidence on the impact of Typhoid Conjugate Vaccine (TCV), a phase 3, double-blind, randomized controlled trial was conducted in Lalitpur, Nepal. 20,000 children aged between 9 months and ≤16 years were vaccinated with a new TCV, or control vaccine. …”